Revolutionary p-tau217 Blood Test Transforms Alzheimer’s Diagnosis and Accelerates Treatment Access
The p-tau217 blood biomarker test has revolutionized Alzheimer’s diagnosis, offering over 90% accuracy and replacing c...
Read More →The p-tau217 blood biomarker test has revolutionized Alzheimer’s diagnosis, offering over 90% accuracy and replacing c...
Read More →A novel nanoparticle platform successfully crosses the blood-brain barrier to deliver gene-silencing therapy for ALS, si...
Read More →Synthetic biology-engineered bacteriophages have successfully cured severe, multi-drug resistant Acinetobacter baumannii...
Read More →An in-vivo epigenetic reprogramming therapy has successfully halted cognitive decline and reversed amyloid and tau patho...
Read More →An implantable optogenetic spinal interface has successfully restored voluntary motor control in patients with complete ...
Read More →A universal mRNA influenza vaccine targeting the conserved hemagglutinin stalk has elicited broad neutralizing antibodie...
Read More →Researchers have successfully transplanted a 3D-bioprinted, vascularized kidney construct into a primate, where it funct...
Read More →A novel engineered psychobiotic therapy targeting the gut-brain axis has achieved an 80% remission rate in patients with...
Read More →An AI-designed senolytic peptide, SEN-77, has successfully cleared senescent cells and reversed epigenetic aging biomark...
Read More →A Phase III trial demonstrates that a personalized mRNA neoantigen vaccine combined with chemotherapy and immunotherapy ...
Read More →A Phase II clinical trial demonstrates that a novel in-vivo CRISPR-Cas12a gene editing therapy safely halts the progress...
Read More →